本页面由Tiger Trade Technology Pte. Ltd.提供服务

美国血液技术

122.06
+3.372.84%
盘前:123.751.69+1.38%05:47 EDT
成交量:89.51万
成交额:1.08亿
市值:55.47亿
市盈率:59.54
高:122.24
开:118.70
低:118.36
收:118.69
52周最高:122.24
52周最低:48.55
股本:4,544.60万
流通股本:4,459.72万
量比:0.77
换手率:2.01%
股息:- -
股息率:- -
每股收益(TTM):2.05
每股收益(LYR):2.05
净资产收益率:11.20%
总资产收益率:6.60%
市净率:6.63
市盈率(LYR):59.54

数据加载中...

2020/05/28

重要事件披露

8-K - Current report
2020/05/20

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/05/05

重要事件披露

Current report, items 2.02 and 9.01
2020/04/17

重要事件披露

8-K - Current report
2020/04/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/03/04

重要事件披露

Current report, item 5.02
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/04

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/02/04

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/04

重要事件披露

Current report, items 2.02 and 9.01
2020/01/27

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/14

重要事件披露

Current report, items 1.02, 7.01, and 9.01
2019/11/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/11/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/11/13

持股变动声明

Statement of changes in beneficial ownership of securities
2019/11/01

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/01

重要事件披露

Current report, items 2.02 and 9.01
2019/10/29

持股变动声明

Statement of changes in beneficial ownership of securities